Rivas and colleagues demonstrated in a murine model that NK cells can control the proliferation of antigen-activated CD4 + T cells, leading to reduced chronic GvHD, potentially through NKG2D receptor-ligand interactions [33]. The gene discussed is CD4; the disease is chronic graft versus host disease.